First-line treatment with Enhertu plus Perjeta (pertuzumab) reduced the risk of disease progression or death by 44% for patients with HER2-positive advanced breast cancer, while Trodelvy plus Keytruda ...

In this first-person essay, author and writing coach Emily Rubin shares her shock and resolve regarding a second breast cancer diagnosis after many years in remission.

Anxiety about scans, bloodwork and similar tests is a common experience for many people living with and beyond cancer, but they are finding creative ways to ease its grip.

Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical ...

D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, that fight turned personal when he received a diagnosis of his own.

See, I’m on a daily dose of steroids that we started during radiation therapy to help with the related edema. Headaches, for my presentation anyway, are the worst parts about brain swelling. The ...

The Trump administration is taking its immigration crackdown to the health care safety net, launching Medicaid spending probes in at least six Democratic-led states that provide comprehensive health ...

The average person takes almost 22,000 breaths each day, but most of us don’t breathe properly. This can become a serious issue for people living with cancer and other chronic conditions who have ...

At six months, people in both groups saw an improvement in physical function, but this was significantly greater in the exercise group. At five years, people assigned to the exercise program had a 28% ...

“The Pap got an upgrade,” boasts an ad for the Teal Wand, the first at-home, self-collecting cervical cancer screening device approved by the Food and Drug Administration. Most cervical cancers are ...

When it comes to improving your health and fighting cancer, you never know where inspiration will arise.

The study surveyed 4,074 oncologists and found that most were reluctant to discuss care goals with patients with advanced cancer who appeared well, had no symptoms or had not exhausted all treatment ...